|
|
 |
|
Viewing report
|
|
|
|
Competitor Analysis: Anti-Infective Peptides
La Merie, Dec 2011, Pages: 44
The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with anti-infective peptides as of December 2011.
Anti-Viral Peptides:
Anti-viral peptides are used to treat infections such as HIV and AIDS, influenza incl. H5N1 strains, hepatitis C virus infections (HCV).
Anti-Bacterial Peptides:
Anti-bacterial peptides are used to treat infectious diseases such as complicated skin and skin structure infections (cSSSI), gram+ and gram- infections, prevention of catheter-related infections, otitis media, gingivitis and many more.
Anti-Fungal Peptides:
Anti-fungal peptides are used to treat infections such as oesophageal candidiasis, aspergillosis, oral candida infections, vaginal yeast infections and many more
KEY FEATURES
The report includes a compilation of current active projects in research and development of anti-infective peptides. In addition, the report lists company-specific R&D pipelines of anti-infective peptides. Competitor projects are listed in a tabular format providing information on:
- Drug Codes
- Target / Mechanism of Action
- Class of Compound
- Company
- Product Category
- Indication
- R&D Stage
- additional comments with a hyperlink leading to the source of information
Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
ABOUT COMPETITOR ANALYSIS SERIES
The Competitor Analysis Series delivers no-frills, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Anti-Infectives - Global Strategic Business Report
Competitor Analysis - Cancer Antibodies in Early Clinical Development
Anti-Infective Drugs Markets
Competitor Analysis: Targeted Therapy of Hepatitis C
Competitor Analysis - Antibody Therapy of Inflammatory and Autoimmune Diseases
Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition
Competitor Analysis: Cancer Vaccines
Competitor Analysis: Cardiovascular Peptides
Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects
Commercializing Peptides in Cancer: The Faster Route to Consider Your Options and Position of Others
|
|
|
|
